Guggenheim Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $90

Moomoo NewsJan 8 18:32 ET · Ratings

Citi Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $70

Moomoo NewsJan 8 12:33 ET · Ratings

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors

BenzingaJan 8 10:23 ET

Calculating The Intrinsic Value Of Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Simply Wall StJan 4 08:12 ET

Is There An Opportunity With Celldex Therapeutics, Inc.'s (NASDAQ:CLDX) 26% Undervaluation?

Yahoo FinanceJan 1 06:33 ET

Celldex Therapeutics Initiates Phase 2 Study of Barzolvolimab for Atopic Dermatitis Treatment

Quiver QuantitativeDec 19, 2024 08:14 ET